Matrix Metalloproteinase 2, Recombinant, Human, His-Tag (MMP-2)

Catalog No : USB-299448
419.55€
0.00€

Shipping cost plus VAT not included , delivery in 7-14 business days

Product name Matrix Metalloproteinase 2, Recombinant, Human, His-Tag (MMP-2)
Catalog No USB-299448
Supplier’s Catalog No 299448
Supplier US Biologicals
Source antigen Recombinant, HEK293 cells
Reactivity
Cross reactivity
Applications
Molecular weight
Storage -20°C
Other names
Grade Highly Purified
Purity ~95% (SDS-PAGE)
Form Supplied as a liquid in Tris, sodium chloride, Brij35.
Reactivity life 12 months
Note For reserch purpose only
Purity ~95% (SDS-PAGE)
Description Matrix metalloproteinase-2 (MMP-2) is a type IV collagenase, which is involved in endometrial menstrual breakdown, regulation of vascularization and the inflammatory response. MMP-2 contains a number of distinct domains: a prodomain that is cleaved upon activation; a catalytic domain containing the zinc binding site; a fibronectin like domain believed to have a role in substrate targeting; and a carboxyl terminal (hemopexin like) domain containing 2 N-linked glycosylation. The MMP-2 can degrade an extensive array of substrates including type IV, V, VII and X collagens as well as gelatin type I. In addition, MMP2 interacts with THBS2, TIMP2, Thrombospondin 1, CCL7 and TIMP4. MMP-2 autocatalytic cleavage in the C-terminal generates the anti-angiogenic peptide, PEX. This process seems to be made possible by binding integrinv/beta3. Defects in the MMP-2 are the cause of Torg-Winchester syndrome (TWS), aka multicentric osteolysis nodulosis and arthropathy (MONA). Source: Recombinant protein corresponding a proform of human MMP2 (Ala30-Cys660), fused to His-tag at C-terminal, expressed in HEK293 cells. Biological Activity: Measured by its ability to cleave the colorimetric peptide substrate, Mca-PLGL-DpaAR-NH2. The specific activity is >1000pmoles/min/ug Storage and Stability: May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.